BHI Feed
Safety Study of Intravenously Administered Human Cord Blood Stem Cells in the Treatment of symptoms Related to Chronic Inflammation. Brian M. Mehling, Louis Quartararo, Marine Manvelyan, Paul Wang, Dong-Cheng Wu Full Link The post Safety Study of Intravenously Administered Human Cord Blood Stem Cells in the Treatment of Symptoms Related to Chronic Inflammation appeared first on Blue Horizon International.
CellR4 2015; 3 (2): e1562 Safety Study of Intravenously Administered Human Cord Blood Stem Cells in the Treatment of Symptoms Related to Chronic Inflammation – Before Author’s Corrections Mehling B. M. , Quartararo L. , Manvelyan M. , Wang P. , Wu D. C. Topic: Stem cells Category: Original Articles Abstract Background: Numerous investigations... Read More » The post Safety Study of Intravenously Administered Human Cord Blood Stem Cells in the Treatment of Symptoms Related to Chronic Inflammation – Before Author’s Corrections appeared first on Blue Horizon International.
Brian M. Mehling1, Louis Quartararo1, Marine Manvelyan*1, Paul Wang1 and Dong-Cheng Wu2,3 1Blue Horizon International, LLC, 214 State Street, Hackensack, New Jersey 07601, USA 2Biochemistry Institute, Wuhan University, Hubei 430071, P.R. China 3Department of Stem Cells, Wuhan Hongqiao Brain Hospital, Wuhan, Hubei 430071, P.R. China *Corresponding author: Marine Manvelyan, Blue Horizon International, LLC, 214 State... Read More » The post Stem Cell Evaluation of Immune response to Intravenously Administered Human Cord Blood Stem Cells in the Treatment of Symptoms Related to Chronic Inflammation appeared first on Blue Horizon International.
CellR4 2018; 6 (2): e2521 Allogeneic umbilical cord blood mononuclear cell therapy for spinal cord injury – a retrospective cohort study Mehling B. M. , Wu D. C. , Quartararo L. , Roman S. J. , Pickoff A. S. , Stolfi A. , Szelestey B. , Rutherford R. , Manvelyan M. Topic: Stem cells ... Read More » The post Allogeneic umbilical cord blood mononuclear cell therapy for spinal cord injury – a retrospective cohort study appeared first on Blue Horizon International.
J Clin Med Res. 2020 Nov; 12(11): 747–751. Published online 2020 Nov 3. doi: 10.14740/jocmr4354 PMCID: PMC7665865 PMID: 33224377 A Retrospective Study of Stromal Vascular Fraction Cell Therapy for Osteoarthritis Brian Mehling,a Milan Hric,b Adriana Salatkova,b Robert Vetrak,b Doreen Santora,a Miriama Ovariova,c Renata Mihalyova,c and Marine Manvelyana,d Author information Article notes Copyright and License information PMC... Read More » The post A Retrospective Study of Stromal Vascular Fraction Cell Therapy for Osteoarthritis appeared first on Blue Horizon International.
Safety study of cultured human Wharton’s Jelly mesenchymal stem cell therapy for multiple indications – a retrospective descriptive study Mehling B. M. , Wu D. C. , Santora D. , O’Gorman E. , Novakova K. , Spencer G. , Thomas C. , Grant R. , Rutherford R. , Mihályová R. Topic: Regenerative Medicine, Stem cells... Read More » The post Safety study of cultured human Wharton’s Jelly mesenchymal stem cell therapy for multiple indications – a retrospective descriptive study appeared first on Blue Horizon International.